DigestRedComo funciona
Red
/
Empresas
AI
No verificado

AIRNA

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMercado laboralSalud

9 Comunicados de prensa

Ver todos los comunicados de prensa
28/04/2026
Eventos
Industria
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Medicina - Varios
AIRNA to Present New Preclinical Data on RNA-Editing Therapeutic Pipeline at ASGCT Annual Meeting
Fuente
AIRNA
Editor
Business Wire
1.00
0
07/04/2026
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
AIRNA Announces First Patient Dosed in Phase 1 Trial of AIR-001, Potential Best-in-Class RNA-Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)
Fuente
AIRNA
Editor
Business Wire
1.00
0
01/10/2025
Biotecnología
Salud
Ciencia
Mercado laboral
AIRNA Appoints Allison Dorval as Chief Financial Officer and Niru Subramanian as Chief Operating Officer
Fuente
AIRNA
Editor
Business Wire
1.00
0
06/08/2025
Biotecnología
Salud
Ciencia
Mercado laboral
AIRNA Appoints Tamara Joseph as Chief Legal Officer and Kristina Storey as Head of Regulatory Affairs
Fuente
AIRNA
Editor
Business Wire
1.00
0
13/05/2025
Eventos
Biotecnología
Farmacéutica
Salud
AIRNA Presents Data Supporting RNA Editing Approach for Alpha-1 Antitrypsin Deficiency (AATD) at 28th ASGCT Annual Meeting
Fuente
AIRNA
Editor
Business Wire
1.00
0
16/04/2025
Mercado laboral
Industria
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
AIRNA Appoints Jacob Elkins Chief Medical Officer
Fuente
AIRNA
Editor
Business Wire
1.00
0
01/04/2025
Ciencia
Biotecnología
Medicina - Varios
Sanidad
Salud
Farmacéutica
AIRNA Raises Oversubscribed $155 Million Series B Financing to Fund Phase 1/2 Clinical Trial for Alpha-1 Antitrypsin Deficiency and Future Pipeline
Fuente
AIRNA
Editor
Business Wire
1.00
0
30/01/2025
Biotecnología
Farmacéutica
Salud
Mercado laboral
AIRNA Appoints Matthew Hawryluk as Chief Business Officer
Fuente
AIRNA
Editor
Business Wire
1.00
0
31/07/2024
Salud
Biotecnología
Medicina - Varios
Ciencia
Mercado laboral
AIRNA Raises Oversubscribed $60 Million Financing to Advance New Class of RNA Editing Medicines and Progress Best-in-Class AATD Program into the Clinic
Fuente
AIRNA
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0